Yale Cancer Center(@YaleCancer) 's Twitter Profileg
Yale Cancer Center

@YaleCancer

Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.

ID:851106744

linkhttp://yalecancercenter.org calendar_today28-09-2012 13:59:18

8,4K Tweets

15,8K Followers

1,8K Following

Follow People
Yale School of Medicine(@YaleMed) 's Twitter Profile Photo

The first-ever U.S. trial of the varenicline for cessation shows positive results: Researchers at Yale Psychiatry and Yale Cancer Center say 45% of study participants were able to . is better known by the brand name . brnw.ch/21wJQDq

The first-ever U.S. trial of the #drug varenicline for #vaping cessation shows positive results: Researchers at @YalePsych and @YaleCancer say 45% of study participants were able to #quit. #Varenicline is better known by the brand name #Chantix. brnw.ch/21wJQDq
account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

Join us tomorrow at 9am as we welcome Dr. Benjamin Izar bizarMD to present our : 'Dissecting and Overcoming Different Shades of Immune Evasion.' Attend in-person at Smilow Auditorium or watch via Zoom.
bit.ly/4bFZteR
Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp

Join us tomorrow at 9am as we welcome Dr. Benjamin Izar @BizarMd to present our #GrandRounds: 'Dissecting and Overcoming Different Shades of #Cancer Immune Evasion.' Attend in-person at Smilow Auditorium or watch via Zoom. bit.ly/4bFZteR @SmilowCancer @YaleMed @YNHH
account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

“Since we don’t see an improved survival benefit (from end-of-life systemic treatment), oncologists should revisit their goals of care conversations with patients, and this information in the study should be explained to patients.” Dr. Maureen Canavan, in a new study published in

account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

.Rory M. Shallis, MD presents 'The Future of Acute Myeloid Leukemia Treatment: What's Next' in a The Leukemia & Lymphoma Society webinar: 'You need to understand what is current standard of care for AML before you can talk about what the future holds.'
Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp YaleHematology

.@Dr_RoryShallis presents 'The Future of Acute Myeloid Leukemia #AML Treatment: What's Next' in a @LLSusa webinar: 'You need to understand what is current standard of care for AML before you can talk about what the future holds.' @SmilowCancer @YaleMed @YNHH @YaleHematology
account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

We’re pleased to announce that the Foundation for the Accreditation of Cellular Therapy (FACT) has granted Yale Cancer Center and Smilow Cancer Hospital reaccreditation for cellular therapy and .
yalecancercenter.org/news-article/y…
Yale School of Medicine Yale New Haven Hosp YaleHematology

We’re pleased to announce that the Foundation for the Accreditation of Cellular Therapy (FACT) has granted Yale Cancer Center and @SmilowCancer reaccreditation for cellular therapy and #stemcelltransplantation. yalecancercenter.org/news-article/y… @YaleMed @YNHH @YaleHematology
account_circle
Smilow Cancer Hospital(@SmilowCancer) 's Twitter Profile Photo

Register for our free webinar:
➡️Smilow Shares:
➡️Wednesday, May 15
➡️7:00pm
Hosted by Dr. Jennifer Moliterno, MD, FAANS, with presenters Mary Barden, MD and Miri Kim, MD.
Register ⬇️ yale.zoom.us/.../register/W…
Yale Cancer Center Yale School of Medicine Yale New Haven Hosp Yale Department of Neurosurgery

Register for our free webinar: ➡️Smilow Shares: #BrainTumorAwareness ➡️Wednesday, May 15 ➡️7:00pm Hosted by Dr. Jennifer Moliterno, MD, FAANS, with presenters @MaryMBarden and Miri Kim, MD. Register ⬇️ yale.zoom.us/.../register/W… @YaleCancer @YaleMed @YNHH @YNeurosurgery
account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

Congratulations Dr. Dmitry Kozhevnikov Dmitry Kozhevnikov, DO, recipient of a 2024 Rozenkranz Award for Pedagogical Advancement for his project: 'Managing Acute Decompensation in Life-Limiting Illness (MADLI): A Novel Simulation Curriculum.'
Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale Poorvu Center

Congratulations Dr. Dmitry Kozhevnikov @palliprof, recipient of a 2024 Rozenkranz Award for Pedagogical Advancement for his project: 'Managing Acute Decompensation in Life-Limiting Illness (MADLI): A Novel Simulation Curriculum.' @SmilowCancer @YaleMed @YNHH @PoorvuCenter
account_circle